Waters Corporation (WAT)
After hours:
| Previous close | 336.42 |
| Open | 338.69 |
| Bid | 139.54 x 900 |
| Ask | 353.72 x 800 |
| Day's range | 338.69 - 352.12 |
| 52-week range | 231.90 - 363.80 |
| Volume | |
| Avg. volume | 420,477 |
| Market cap | 20.828B |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | 34.49 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 26 Nov 1996 |
| 1y target est | N/A |
- PR Newswire
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument
Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations. This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution. It enhances and complements Waters best-in-class ACQUITY Premier Liquid
- PR Newswire
Waters Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results
Waters Corporation (NYSE: WAT) today announced its financial results for the first quarter of 2024.
- PR Newswire
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns
Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns. Waters has implemented a unique combination of novel packing materials and MaxPeak™ Premier High-Performance Surface (HPS) technology into the columns to help scientists accelerate the development of gene-based therapeutics, including cell & gene, mRNA and LNPs.
